[Radiation protective effect of low molecular weight thymus preparations].
The antiradiation efficiency of low molecular thymic preparations (vilosen, thymogen) was determined. The therapeutic activity of thymic preparations is due to their influence on basic radiation injury syndromes (hemopoietic, gastrointestinal, immunodepressive). The protective mechanisms and perspectives of thymic preparations using in pathogenic therapy of radiation diseases are discussed.
V A
VA
Baraboĭ
S I
SI
Ialkut
Z D
ZD
Savtsova
V A
VA
Zinchenko
V M
VM
Zhukova
M Iu
MIu
Zaritskaia
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000818:Animals; D001772:Blood Cell Count / Q000187:drug effects; D001853:Bone Marrow / Q000187:drug effects / Q000473:pathology; D004151:Dipeptides; D007413:Intestinal Mucosa / Q000187:drug effects / Q000473:pathology; D008297:Male; D051379:Mice; D008938:Mitosis / Q000187:drug effects; D010455:Peptides / Q000627:therapeutic use*; D011833:Radiation Injuries, Experimental / Q000188:drug therapy* / Q000473:pathology; D011837:Radiation-Protective Agents; D013949:Thymus Extracts / Q000627:therapeutic use*
D000276:Adjuvants, Immunologic; D004151:Dipeptides; D010455:Peptides; D011837:Radiation-Protective Agents; D013949:Thymus Extracts; C059606:iilozen; C060736:thymogen
Protivoluchevoe deĭstvie nizkomolekuliarnykh preparatov vilochkovoĭ zhelezy.